Penn's Division of Hematology/Oncology in the Department of Medicine provides comprehensive hematology and medical oncology research. The division, with its colleagues in other medical specialties, is an integral part of Penn's Abramson Cancer Center, an NCI-designated cancer center.
Specialized resources and research program include:
Penn Hematology/Oncology investigators continue to publish high profile and important findings in diverse fields, ranging from the most fundamental cellular investigations, to the most leading edge translational and clinical research.
Investigators with Penn Hematology/Oncology are focused on translating laboratory work into novel therapies and practice-changing discoveries.
The Penn Blood Disorders Center conducts cutting-edge clinical research in non-malignant blood disorders.
Penn's Abramson Cancer Center, an NCI-designated comprehensive cancer center, oversees one of the largest clinical trial programs in the country, with more than 200 trials available at any one time.